Literature DB >> 8567767

The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques.

B C Tarlatzis1, G Grimbizis, F Pournaropoulos, J Bontis, S Lagos, E Spanos, S Mantalenakis.   

Abstract

One of the main endocrinological disturbances in patients with polycystic ovarian syndrome (PCOS) is the increased baseline concentrations of luteinizing hormone (LH) and consequently a high LH:follicle-stimulating hormone (FSH) ratio. The aim of this study was to assess the relationship between the baseline LH:FSH ratio with the stimulation response and the miscarriage risk in PCOS women stimulated for assisted reproduction techniques (ART) with and without gonadotrophin-releasing hormone analogue (GnRHa). Two groups of PCOS patients were analysed retrospectively. Group A (n = 20, 20 cycles) consisted of women stimulated with human menopausal gonadotrophin (HMG), and group B (n = 128, 162 cycles) comprised women stimulated with buserelin-long/HMG. LH and FSH concentrations were measured during the early follicular phase (days 4-6) in a preceding spontaneous or progestin-induced cycle. The following parameters were assessed: number of follicles developed, number of oocytes obtained and percentage of mature oocytes, as well as number of abortions and live births. In group A, the baseline LH:FSH ratio was correlated inversely with the number of follicles developed (P < 0.05), the number of oocytes obtained (P < 0.05) and the percentage of mature oocytes (P < 0.05). In group B, no correlation was found between the LH:FSH ratio and the number of follicles and oocytes, because their numbers were relatively constant irrespective of the baseline LH:FSH ratio, but a significant inverse correlation was noted with the percentage of mature oocytes (P < 0.001). However, a comparison of the slopes of the curve indicated a better correlation between the LH:FSH ratio and the percentage of mature oocytes in group A than in group B (P < 0.05). These findings were also confirmed when patients were subdivided according to the LH:FSH ratio (< 3 or > or = 3). Furthermore, in women who miscarried, the mean LH:FSH ratio was significantly higher than in women having a live birth. In conclusion, in PCOS patients stimulated with HMG, a high basal LH:FSH ratio appears to have an adverse effect on the number of follicles and oocytes, as well as on oocyte maturity. On the other hand, the administration of GnRHa in the long protocol seems to reverse this detrimental effect on follicle and oocyte development. Furthermore, a higher LH:FSH ratio seems to predict a greater possibility for miscarriage, despite the use of GnRHa.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8567767     DOI: 10.1093/oxfordjournals.humrep.a135742

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  15 in total

Review 1.  Treatment of polycystic ovary patients undergoing IVF.

Authors:  P N Barri; B Coroleu; F Martinez; J M Traver; A Veiga; G Calderon
Journal:  J Assist Reprod Genet       Date:  1997-01       Impact factor: 3.412

Review 2.  The significance of high follicular-phase luteinizing hormone levels in the treatment of women with polycystic ovarian syndrome by in vitro fertilization.

Authors:  B C Tarlatzis; G Grimbizis
Journal:  J Assist Reprod Genet       Date:  1997-01       Impact factor: 3.412

3.  Hyper response to ovarian stimulation affects the follicular fluid metabolomic profile of women undergoing IVF similarly to polycystic ovary syndrome.

Authors:  Fernanda Bertuccez Cordeiro; Thaís Regiani Cataldi; Beatriz Zappellini de Souza; Raquel Cellin Rochetti; Renato Fraietta; Carlos Alberto Labate; Edson Guimarães Lo Turco
Journal:  Metabolomics       Date:  2018-03-16       Impact factor: 4.290

4.  Obesity is not associated with the poor pregnancy outcome following intracytoplasmic sperm injection in women with polycystic ovary syndrome.

Authors:  Funda Akpınar; Berfu Demir; Serdar Dilbaz; Iskender Kaplanoğlu; Berna Dilbaz
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-08-08

5.  Spindle and chromosome configurations of in vitro-matured oocytes from polycystic ovary syndrome and ovulatory infertile women: a pilot study.

Authors:  Rodolpho C Vieira; Ionara D Barcelos; Elisa M Ferreira; Wellington P Martins; Rui A Ferriani; Paula A Navarro
Journal:  J Assist Reprod Genet       Date:  2010-09-04       Impact factor: 3.412

Review 6.  Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome.

Authors:  Ana Teresa Brinca; Ana Cristina Ramalhinho; Ângela Sousa; António Hélio Oliani; Luiza Breitenfeld; Luís A Passarinha; Eugenia Gallardo
Journal:  Biomedicines       Date:  2022-05-27

7.  What is the best treatment for women with polycystic ovarian syndrome and high LH/FSH ratio? A comparison among in vitro fertilization with GnRH agonist, GnRH antagonist and in vitro maturation.

Authors:  Y Ganor-Paz; Y Friedler-Mashiach; Y Ghetler; A Hershko-Klement; A Berkovitz; O Gonen; A Shulman; A Wiser
Journal:  J Endocrinol Invest       Date:  2016-01-21       Impact factor: 4.256

8.  Vitamin D Receptor TaqI Gene Variant in Exon 9 and Polycystic Ovary Syndrome Risk.

Authors:  Morteza Bagheri; Isa Abdi Rad; Nima Hosseini Jazani; Fariba Nanbakhsh
Journal:  Int J Fertil Steril       Date:  2013-07-31

9.  In Vitro Activation of Follicles and Fresh Tissue Auto-transplantation in Primary Ovarian Insufficiency Patients.

Authors:  Jun Zhai; Guidong Yao; Fangli Dong; Zhiqin Bu; Yuan Cheng; Yorino Sato; Linli Hu; Yingying Zhang; Jingyuan Wang; Shanjun Dai; Jing Li; Jing Sun; Aaron J Hsueh; Kazuhiro Kawamura; Yingpu Sun
Journal:  J Clin Endocrinol Metab       Date:  2016-08-29       Impact factor: 5.958

10.  Association between The Number of Retrieved Mature Oocytes and Insulin Resistance or Sensitivity in Infertile Women with Polycystic Ovary Syndrome.

Authors:  Fatemeh Hassani; Shahrbanoo Oryan; Poopak Eftekhari-Yazdi; Masood Bazrgar; Ashraf Moini; Nahid Nasiri; Azadeh Ghaheri
Journal:  Int J Fertil Steril       Date:  2018-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.